A total of 291 products derived recombinant DNA technologies have been approved as of September 25, this year, according to data released by the Korea Food and Drug Administration.
The data showed that 13 manufacturers have produced 129 items, and 162 items are being introduced by 24 importers.
The use of recombinant DNA technology has become commonplace as new products from genetically a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.